Perpective Management- Pharmaceutical Industry Overview
-
Upload
sdusane1 -
Category
Leadership & Management
-
view
31 -
download
2
Transcript of Perpective Management- Pharmaceutical Industry Overview
![Page 1: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/1.jpg)
Sagar DusaneMMS- B-11-(2015-17)AIAIMS- Mumbai 01
Perspective Management
![Page 2: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/2.jpg)
History
• Sushruta Samhita, an Indian Ayurvedic treatise 6th century BC
• Ancient Egyptian papyri such as the Ebers Papyrus of 1550 BC.
• Ancient Greece, Diocles of Carystus (4th century BC) medicinal properties of plants
• Galen is the father of pharmacy• Prof. William Procter, father of American
pharmacy
![Page 3: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/3.jpg)
GlaxoSmithKline plc (GSK)
• Founded 2000; 15 years ago
• Headquarters- Brentford, London, United Kingdom
• Products- Pharmaceuticals, vaccines, oral healthcare
products, nutritional products,
over-the-counter medicines.
• Number of employees - 96,575 (2015)
• Slogan- "Do more, feel better, live longer"
![Page 4: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/4.jpg)
Pfizer, Inc.
• Founded 1849; 166 years ago• Headquarters New York City, New York, United
States• Number of employees- 78,000 (2014)• Slogan- Doing things differently
![Page 5: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/5.jpg)
Products of GSK
The GSK India product portfolio includes prescription medicines and vaccines. GSK prescription medicines range across therapeutic areas and GSK also offer a range of vaccines.
![Page 6: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/6.jpg)
Category of Drugs
• Antibiotic drugs • Analgesic drugs• Anticancer drugs• Vaccines• Derma products
![Page 7: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/7.jpg)
Antibiotics
• Augmentin DDS• Augmentin (I.V.)• Augmentin tabs• Cetzin A
![Page 8: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/8.jpg)
ANALGESICS
• Calpol• Calpol T
![Page 9: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/9.jpg)
VACCINES
•Engerix-B : Hepatitis B Vaccine•Havrix : Inactivated Hepatitis A virus Vaccine
![Page 10: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/10.jpg)
Products of Pfizer
Pfizer products reflect their focus on innovation. A great insight leads to strenuous research, which in turn forms the basis of a great product. There can be no compromise when it comes to patient health. At Pfizer, every product is designed to be the best in the market
![Page 11: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/11.jpg)
Anti-Allergic
• LC-OD M (Levocetrizine + Montelukast)• Levocetrizine Group (Levocetrizine)• LC-OD Plus (Levocetrizine + Montelukast
+Dihydrochloride)
![Page 12: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/12.jpg)
Anti-Diabetic
• Amlogard-Met (Amlodipine + Metoprolol)• Bidiab (Metformin)• Immediab (Glimepiride)• Immediab-M (Metformin Glimepiride)
![Page 13: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/13.jpg)
Multivitamins
Becosule Capsules (Vit.B- Complex+ Vit.C)
![Page 15: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/15.jpg)
![Page 16: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/16.jpg)
Market segmentation
![Page 17: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/17.jpg)
Market segmentation
9147.74; 28%
5826.39; 17%
4702.38; 14%
2749.39; 8%
2705.95; 8%
2514.09; 7%
1838.96; 5%
2409.11; 7%
1882.4; 6%
Respiratory
Central nervous system
Anti-Virals
Anti-Bacterials
Metabolic
Vaccines
Oncology and emesis
Cardiovascular
Other
3538; 10%
5763; 15%
2633; 7%
1372; 4%
0; 0%
1669; 5%
2434; 7%
17958; 48%
1368; 4%
Respiratory
Central nervous system
Urology
Ophthalmology
Vaccines
Artrithis
Oncology and emesis
Cardiovascular
Other
![Page 18: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/18.jpg)
Corporate views and values
Mission - to improve the quality of human
life
Purpose - dedicated to better health and
greater access to healthcare.
Research based pharmaceutical company
Shape a flexible R&D organisation that can respond to the challenges and the opportunities
- become the world's most valued company to patients, customers, colleagues, investors, business partners.
- dedicated to better health and greater access to healthcare.
Growth through innovation
Research based pharmaceutical company
![Page 19: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/19.jpg)
Customer - understanding and responding to their
often changing needs.
Personnel policy -GSK business employs over 100,000
people in 116 countries Over 15,000 people work in research
teams to discover new medicines For employees, we create an environment
that allows them to do their best work by being themselves
Stakeholders - we must provide the right
information in a timely and effective way.
- deeply committed to meeting the needs of our customers, and we constantly focus on customer satisfaction
- Pfizer employs 122,000 people in 60 countries and has sales in more than 150 countries.
People are the cornerstone of Pfizer's success, we value our diversity as a source of strength, and we are proud of Pfizer's history of treating people with respect and dignity
- We work with stakeholders to share knowledge, skills and goals on how to prevent or manage diseases, how to get medicine to the people who need it, and how to promote good health.
Corporate views and values
![Page 20: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/20.jpg)
Events (risks)
• Product Recall & Litigations • Patent Expiration • BRIC Competition & Generics• Free Access & Price Dumping • Public opinion pressure
![Page 21: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/21.jpg)
Markets (opportunities)
• Cancer Treatment• Pandemic & Bioterrorism• Healthcare & Animal• Online Pharmacy • Developing World
![Page 22: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/22.jpg)
Market Area
![Page 23: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/23.jpg)
Market Area GlaxoSmithKline Pharmaceuticals Ltd.
Parent Company GlaxoSmithKline Plc
Category Pharmaceutical and Healthcare companies
Sector Health Care
Tagline/ Slogan Do more, feel better, live longer
USPGlaxoSmithKline is the UK’s largest and world’s second largest pharmaceutical company
![Page 24: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/24.jpg)
Overview (Glaxosmithkline)
GSK Worldwide-• Focus• Strength• Trade• Rnd• Social responsibility programmes
![Page 25: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/25.jpg)
SWOT Analysis for GSKStrength
• Top 5 largest pharmaceutical companies• Innovation• Previous achievements• Strong R&d focus• Global presence • Employees strength
Weakness• Safety of drugs affects• Patent expiry for a number of bulk-buster products
Opportunity• Good network with competitor• Increasing awareness about healthcare needs• Global penetration • Increasing demand for quality healthcare solutions
Threats• Risk of unsuccessful new Products• Regulatory environment• Economic meltdown
![Page 26: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/26.jpg)
Patient safety
Intellectual property
Supply chain and quality
Legal, regulatory, and
compliance
Economic and financial risks
RISK OF GSK
![Page 27: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/27.jpg)
Pfizer
Pfizer
Parent Company Pfizer Ltd
Category Pharmaceutical
Sector Health care
Tagline/ Slogan Doing things differently
USPPfizer Inc discovers, develops, manufactures, and markets leading prescription drugs
![Page 28: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/28.jpg)
SWOT Analysis for Pfizer Strength
• Largest pharmaceutical company spread over 50 countries• Excellent research and development (R&D) • 100,000 employees • Strong brand name and recall globally
Weakness
• Tough competition from other major pharmacy brands • Negative brand image due to involvement in largest healthcare fraud of marketing its drug illegally
Opportunity
• Strategic agreements with other pharmaceutical companies • Increasing awareness about healthcare needs• Global penetration through mergers and acquisitions• Increasing demand for quality healthcare solutions
Threats
• Risk of unsuccessful new Products• Regulatory environment is becoming more & more stringent• Economic slowdown in European markets
![Page 29: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/29.jpg)
Geographic
Foreign exchange
Legal
Integrated risk
RISK FOR PFIZER
![Page 30: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/30.jpg)
PORTER`S FIVE FORCES ANALYSIS
![Page 31: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/31.jpg)
External analysis by Porter’s five forces model
Organization Threat of New entrants
Suppliers bargaining
power
Buyers Bargaining
power
Rivalry from competitors
Threat of product
substitute
GlaxoSmithKline
Low Low Low High High
Pfizer Low Low Low High High
![Page 32: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/32.jpg)
Top 10 Exporting countries1. Germany: (15.2%)
2. Switzerland: (10.5%)
3. Belgium: (9%)
4. France: (7.6%)
5. United States: (7.2%)
6. United Kingdom: (6.9%)
7. Italy: (6.5%)
8. Ireland: (5.8%)
9. Netherlands: (4.7%)
10. India: (3.1%)
![Page 34: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/34.jpg)
Company Overview
• Research based, global pharmaceutical company• Discovers, develops, manufactures and markets prescription drugs
![Page 35: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/35.jpg)
The Problem With Pfizer's $17 Billion Buy
Buying hospira hsp +%, the Lake Forest, Illinois-based hospital-focused drug maker, for $17 billion in cash and assumed debt to beef up its generic business
![Page 36: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/36.jpg)
Pfizer accused of testing new drug without ethical approval
• Pfizer did not obtain official approval before testing a new drug on children during a meningitis epidemic in Nigeria five years
• Pfizer said that 15000 people died during the epidemic
![Page 37: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/37.jpg)
Most ethical challenges in history
• 1996: Eleven children died and many were disabled • 1998: The FDA approved Trovan for use in adults only•1999: The European Union banned Trovan.
• 2006: A Nigerian panel concluded that the Pfizer trial was an “illegal
• 2010: Pfizer finally settled the suits for about $75 million
![Page 38: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/38.jpg)
Pfizer’s Latest Twist on ‘Pay for Delay’
• The controversial practice, known as "pay for delay"
• In 2008, the company settled patents litigations with
Ranbaxy
• Agreed to pay the $2.3 billion in fines
![Page 39: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/39.jpg)
• Glaxosmithkline drug issue• Risked damaging the health of people around the world
GlaxoSmithKline's bribes are evidence that Big
Pharma isn't working
![Page 40: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/40.jpg)
• Animal studies for an experimental therapy
• Bribery of doctors in a position to prescribe its drugs.
GlaxoSmithKline's China R&D audit found ethical
![Page 41: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/41.jpg)
No doctors to promote its drugsStop tying compensation for sales representatives
GlaxoSmithKline to Quit Paying Doctors for Promotional Talks
![Page 42: Perpective Management- Pharmaceutical Industry Overview](https://reader036.fdocuments.us/reader036/viewer/2022062401/58d12b121a28abe3298b4ffd/html5/thumbnails/42.jpg)